PWA
PMD

Provenance Wealth Advisors’s Psychemedics Corporation PMD Stock Holding History

Provenance Wealth Advisors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-772
Closed -$1.78K – 603
2024
Q3 		$1.78K Hold
772
– – ﹤0.01% 473
2024
Q2 		$1.87K Hold
772
– – ﹤0.01% 380
2024
Q1 		$2.26K Hold
772
– – ﹤0.01% 399
2023
Q4 		$2.29K Hold
772
– – ﹤0.01% 436
2023
Q3 		$3.06K Buy
+772
New +$3.44K ﹤0.01% 292

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Provenance Wealth Advisors's PMD Position: Q4 2024 in Review

Provenance Wealth Advisors sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 772 shares — an estimated $1.78K sold.

Provenance Wealth Advisors first reported a position in PMD in Q3 2023 and held it in 5 quarters. The position peaked at $3.06K in Q3 2023. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Provenance Wealth Advisors reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Provenance Wealth Advisors sold 772 Psychemedics Corporation shares in Q4 2024, an estimated $1.78K.
  • Provenance Wealth Advisors first reported a position in Psychemedics Corporation in Q3 2023 and held it in 5 quarters.
  • Provenance Wealth Advisors's Psychemedics Corporation position peaked at $3.06K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Provenance Wealth Advisors's 13F filing for Q4 2024, filed 15 Aug 2025.